National and Kapodistrian University of Athens
Πρωτεομική ανάλυση για την ανίχνευση βιοδεικτών στις φλεγμονώδεις νόσους του εντέρου
Abstract
dc:descriptionObjectiveAim of this thesis was to reveale biomarkers to understand the pathogenesis, early diagnosis and response to IFX. For this purpose, differential expression of proteins in serum of children and adults with Crohn’s disease (CD) was measured, using proteomic techniques. The adult group included subjects treated with IFX and divided into three groups according to clinical and serological response to therapy. Materials & MethodsSerum samples from adults and children with active CD and adults who either had achieved clinical and serological remission (Rm), or response (Rs) and/or were primary non responders (PNRs) to IFX were subjected to two-dimensional Gel Electrophoresis. Following relative quantitation of protein spots exhibiting differential expression among the groups by densitometry, and further characterization by MALDI-TOF-MS. Results were further confirmed by Western blot analysis.ResultsClusterin (CLUS) was found to be significantly expressed in adults, whereas the Ceruloplasmin (CERU) and Apolipoprotein B-100 (APOB) were found to be significantly over-expressed in children population indicating that those expressions might be implicated on the onset or progression of CD. In the PNR and Rs groups, apolipoprotein A-I (APOΑ1), apolipoprotein E (APOE), complement C4-B (CO4B), plasminogen (PLMN), serotransferrin (TRFE), beta-2-glycoprotein 1 (APOH), and clusterin (CLUS) were found to be up-regulated, whereas their levels displayed no changes in the Rm group when compared to baseline samples. Additionally, leucine-rich alpha-2-glycoprotein (A2GL), vitamin D-binding protein (VTDB), alpha-1B-glycoprotein (A1BG) and complement C1r subcomponent (C1R) were significantly increased in the serum of the Rm group. ResultsThrough the incorporation of proteomics technologies, novel serum marker-molecules demonstrating high sensitivity and specificity are introduced, hence offering an innovative approach regarding the evaluation of CD patients’ response to IFX therapy and early onset of disease.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vaiopoulou, Anna
- Βαϊοπούλου, Άννα
Subjects
dc:subject × 11Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35998